Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies

References

1. 1.↵
   1. Potts J. T. Jr..,
   2. Kronenberg H. M.,
   3. Rossenblatt M.

   Parathyroid hormone: chemistry, biosynthesis, and mode of action. Adv. Protein Chem. 1982, 35, 323– 396.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Frelinger A. L.,
   2. Zull J. E.

   Oxidized forms of parathyroid hormone with biological activity: separation and characterization of hormone forms oxidized at methionine 8 and methionine 18. J. Biol. Chem. 1984, 259 (9),5507– 5513.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Reynolds D. W.,
   2. Facchine K. L.,
   3. Mullaney J. F.,
   4. Alsante K. M.,
   5. Hatajik T. D.,
   6. Motto M. G.

   Available guidance and best practices for conducting forced degradation studies. Pharm. Technol. 2002, 26 (2),48– 56.

   OpenUrl
4. 4.↵
   1. Capasso S.,
   2. Mazzarella L.,
   3. Sorrentino G.,
   4. Balboni G.,
   5. Kirby A. J.

   Kinetics and mechanism of the cleavage of the peptide bond next to asparagine. Peptides 1996, 17 (6),1075– 1077.

   OpenUrlPubMed
5. 5.↵
   1. Capasso S.,
   2. Mazzarella L.,
   3. Kirby A. J.,
   4. Salvadori S.

   Succinimide-mediated pathway for peptide bond cleavage: kinetic study on an Asn-Sar containing peptide. Peptide Science 1996, 40 (5),543– 551.

   OpenUrl
6. 6.↵
   1. Schagger H.,
   2. von Jagow G.

   Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166 (2),368– 379.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Edman P.

   On the mechanism of the Phenyl Isothiocyanate degradation of peptides. Acta Chem. Scand. 1956, 10, 761– 768.

   OpenUrlWeb of Science
8. 8.↵
   1. Hewick R. M.,
   2. Hunkapillar M. W.,
   3. Hood L. E.,
   4. Dreyer W. J.

   A Gas—liquid solid phase peptide and protein sequenator. J. Biol. Chem. 1981, 256, 7990– 7997.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Tyler-Cross R.,
   2. Schirch V.

   Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. J. Biol. Chem. 1991, 266 (33),22549– 22556.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Geiger T.,
    2. Clarke S.

    Deamidation, isomerization, and racemization at sparaginyl and aspartyl residues in peptides: succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 1987, 262 (2),785– 794.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Nabuchi Y.,
    2. Fujiwara E.,
    3. Kuboniwa H.,
    4. Asoh Y.,
    5. Ushio H.

    Oxidation of recombinant human parathyroid hormone: effect of oxidized position on biological activity. Pharm. Res. 1992, 12 (12),2049– 2052.

    OpenUrl
12. 12.↵
    1. Nabuchi Y.,
    2. Fujiwara E.,
    3. Kuboniwa H.,
    4. Asoh Y.,
    5. Ushio H.

    Stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residue. Pharm. Res. 1997, 14 (12),1685– 1690.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Smyth D. G.,
    2. Stein W. H.,
    3. Moore S.

    The sequence of amino acid residues in bovine pancreatic ribonuclease: revisions and confirmations. J. Biol. Chem. 1963, 238, 227– 234.

    OpenUrlFREE Full Text
14. 14.↵
    1. Chu J. W.,
    2. Yin J.,
    3. Wang D. I.,
    4. Trout B. L.

    A structural and mechanistic study of the oxidation of methionine residues in hPTH(1–34) via experiments and simulations. Biochemistry 2004, 43 (44),14139– 14148.

    OpenUrlPubMed
15. 15.↵
    1. Bhatt N. P.,
    2. Patel K.,
    3. Borchardt R. T.

    Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone. Pharm. Res. 1990, 7 (6),593– 599.

    OpenUrlPubMed
16. 16.↵
    1. Patel K.,
    2. Borchardt R. T.

    Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residue in hexapeptides. Pharm. Res. 1990, 7 (8),787– 793.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Yan B.,
    2. Steen S.,
    3. Hambly D.,
    4. Valliere-Douglass J.,
    5. Vanden Bos T.,
    6. Smallwood S.,
    7. Yates Z.,
    8. Arroll T.,
    9. Han Y.,
    10. Gadgil H.,
    11. Latypov R. F.,
    12. Wallace A.,
    13. Lim A.,
    14. Kleemann G. R.,
    15. Wang W.,
    16. Balland A.

    Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. J. Pharm. Sci. 2009, 98 (10),3509– 3521.

    OpenUrlPubMed